Cargando…
Platelet-derived growth factor-BB and white matter hyperintensity burden in APOE4 carriers
BACKGROUND: The apolipoprotein-e4 (APOE4) gene increases risk for developing late-onset Alzheimer's disease (AD) and has been linked to increased microvascular dysfunction, including pericyte degeneration and blood-brain barrier breakdown. Platelet-derived growth factor-BB (PDGF-BB) is a glycop...
Autores principales: | Kapoor, Arunima, Nation, Daniel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286493/ https://www.ncbi.nlm.nih.gov/pubmed/35844252 http://dx.doi.org/10.1016/j.cccb.2022.100131 |
Ejemplares similares
-
APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia
por: Mirza, Saira Saeed, et al.
Publicado: (2019) -
Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity
por: Lyall, Donald M., et al.
Publicado: (2019) -
Sex-specific BDNF and APOE ε4 genotype interactions on white matter hyperintensity volume
por: Pitts, Brandon
Publicado: (2020) -
APOE/TOMM
40 genetic loci, white matter hyperintensities, and cerebral microbleeds
por: Lyall, Donald M., et al.
Publicado: (2015) -
Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76
por: Cox, Simon R., et al.
Publicado: (2017)